CHRISTIAN SPAULDING, Cochin Hospital, Paris
REFERENCE: N Engl J Med 2006;355:1093, 1105,1169
Two leading articles in the same edition of the New England Journal of Medicine have investigated the use of drug-eluting stents in primary percutaneous coronary intevention in comparison with bare-metal stents. A group from Paris looked at the sirolimus-eluting stent, while a second group from Amsterdam investigated the paclitaxel-eluting stent. Sarah Maxwell talked with Christian Spaulding whose results showed an improvement in rates of target vessel revascularisation.
Two leading articles in the same edition of the New England Journal of Medicine have investigated the use of drug-eluting stents in primary percutaneous coronary intevention in comparison with bare-metal stents. A group from Paris looked at the sirolimus-eluting stent, while a second group from Amsterdam investigated the paclitaxel-eluting stent. Sarah Maxwell talked with Christian Spaulding whose results showed an improvement in rates of target vessel revascularisation.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.